["{\n\"step_by_step_thinking\": \"The relevant documents primarily discuss therapeutic strategies for Alzheimer's disease, including pharmacological approaches to alleviate symptoms or alter the rate of progression. There is no mention of pioglitazone specifically, nor are there any clinical trial data presented that would suggest it can delay cognitive impairment in people at risk for Alzheimer's disease. Therefore, based on the available information, it appears unlikely that pioglitazone can delay cognitive impairment for individuals at risk for Alzheimer's disease.\",\n\"answer_choice\": \"B\"\n}"]